Stock NEO NEOGENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News NeoGenomics, Inc.

Equities

NEO

US64049M2098

Market Closed - Nasdaq
Other stock markets
 03:59:50 2024-05-30 pm EDT 		5-day change 1st Jan Change
14 USD +1.41% Intraday chart for NeoGenomics, Inc. +0.83% -13.44%
May. 28 NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO CI
May. 02 North American Morning Briefing : Stock Futures -3- DJ

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NeoGenomics to Introduce Comprehensive Lung Solution and Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
AQ
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
BU
NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO
CI
North American Morning Briefing : Stock Futures -3-
DJ
Needham Lowers Price Target on NeoGenomics to $19 From $24 Due to Peer Multiple Compression, Maintains Buy Rating
MT
Neogenomics Seeks M&A
CI
Transcript : NeoGenomics, Inc., Q1 2024 Earnings Call, Apr 30, 2024
NeoGenomics: Q1 Earnings Snapshot
AQ
Earnings Flash (NEO) NEOGENOMICS Reports Q1 Revenue $156.2M, vs. Street Est of $149.7M
MT
NeoGenomics Reports First Quarter 2024 Results
BU
NeoGenomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
NeoGenomics, Inc. Reaffirms Consolidated Earnings Guidance for the Full Year 2024
CI
NeoGenomics Announces Senior Leadership Promotions
BU
NeoGenomics, Inc. Announces Senior Leadership Promotions
CI
NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics
CI
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
BU
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
BU
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
BU
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
AQ
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NEO Stock
  4. News NeoGenomics, Inc.